MINAPHARM Pharmaceuticals Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 1, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,601	1,796	2,408	1,822	1,303	987
Market Cap Growth	210.31%	-25.41%	32.19%	39.82%	32.02%	-5.49%
Enterprise Value	7,299	4,355	4,087	2,625	1,448	1,101
Last Close Price	475.41	160.66	213.62	143.60	100.70	74.31
PE Ratio	46.97	14.02	-	3.09	2.91	3.46
PS Ratio	0.81	0.32	0.62	0.50	0.43	0.42
PB Ratio	0.94	0.41	0.69	0.60	0.67	0.62
P/TBV Ratio	1.07	0.48	0.80	0.70	0.81	0.79
P/FCF Ratio	-	-	-	-	-	3.44
P/OCF Ratio	14.87	8.11	23.53	3.24	6.29	2.26
EV/Sales Ratio	1.05	0.77	1.05	0.73	0.48	0.47
EV/EBITDA Ratio	4.37	3.72	7.63	2.42	1.73	1.77
EV/EBIT Ratio	5.52	4.66	10.91	2.72	1.92	2.04
EV/FCF Ratio	-16.72	-	-	-	-	3.84
Debt / Equity Ratio	0.91	1.24	1.07	0.80	0.64	0.60
Debt / EBITDA Ratio	3.24	4.48	6.67	2.22	1.49	1.54
Debt / FCF Ratio	-	-	-	-	-	3.34
Net Debt / Equity Ratio	0.27	0.58	0.53	0.24	0.14	-0.04
Net Debt / EBITDA Ratio	0.98	2.19	3.47	0.68	0.32	-0.10
Net Debt / FCF Ratio	-3.64	-3.68	-1.44	-1.24	-1.47	-0.23
Asset Turnover	0.55	0.55	0.50	0.66	0.79	0.74
Inventory Turnover	3.31	3.26	2.79	2.82	2.90	2.73
Quick Ratio	1.02	0.79	0.70	0.87	0.92	0.84
Current Ratio	1.49	1.25	1.15	1.46	1.61	1.34
Return on Equity (ROE)	2.89%	4.06%	0.68%	25.32%	26.86%	21.14%
Return on Assets (ROA)	6.56%	5.64%	3.02%	11.05%	12.42%	10.56%
Return on Invested Capital (ROIC)	8.36%	8.71%	5.54%	23.09%	28.67%	25.84%
Return on Capital Employed (ROCE)	14.90%	12.60%	7.20%	22.40%	28.80%	29.10%
Earnings Yield	2.00%	8.74%	-1.33%	33.63%	35.79%	30.47%
FCF Yield	-7.79%	-38.82%	-53.66%	-32.84%	-13.86%	29.06%
Dividend Yield	0.53%	1.56%	0.77%	1.95%	2.90%	3.63%
Payout Ratio	36.96%	25.57%	-	9.43%	10.68%	29.33%
Buyback Yield / Dilution	-	-	3.57%	6.67%	-	-
Total Shareholder Return	0.53%	1.56%	4.34%	8.62%	2.90%	3.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.